Pérez-Castrillón, J.L.; Jódar-Gimeno, E.; Nociar, J.; Lojka, M.; Nikolov, D.; Cereto-Castro, F.; Novković, S.; Tarantino, U.; Mehsen-Cetre, N.; Arranz, P.;
et al. A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients 2025, 17, 672.
https://doi.org/10.3390/nu17040672
AMA Style
Pérez-Castrillón JL, Jódar-Gimeno E, Nociar J, Lojka M, Nikolov D, Cereto-Castro F, Novković S, Tarantino U, Mehsen-Cetre N, Arranz P,
et al. A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients. 2025; 17(4):672.
https://doi.org/10.3390/nu17040672
Chicago/Turabian Style
Pérez-Castrillón, Jose Luis, Esteban Jódar-Gimeno, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz,
and et al. 2025. "A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency" Nutrients 17, no. 4: 672.
https://doi.org/10.3390/nu17040672
APA Style
Pérez-Castrillón, J. L., Jódar-Gimeno, E., Nociar, J., Lojka, M., Nikolov, D., Cereto-Castro, F., Novković, S., Tarantino, U., Mehsen-Cetre, N., Arranz, P., MartÃnez Ostalé, C., GarcÃa-Bea, A., & Gilaberte, I.
(2025). A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency. Nutrients, 17(4), 672.
https://doi.org/10.3390/nu17040672
